Literature DB >> 14761717

Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis.

John R Ebright1, Neelima Penugonda, William Brown.   

Abstract

We report a retrospective review of all cases of Staphylococcus lugdunensis bacteremia identified during a period of more than 10 years (January 1990 to May 2002) in a large medical center. Twenty-one cases occurred over that period; 20 cases were available for review. In six instances, the organism appeared to be clinically significant and was most commonly related to a vascular line infection. No deaths, secondary suppurative complications, prolonged bacteremia, or prolonged fever appeared to be caused by S. lugdunensis in our experience. Twenty-five percent of our isolates were resistant to multiple antibiotics, including oxacillin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761717     DOI: 10.1016/j.diagmicrobio.2003.08.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  16 in total

1.  IsdC from Staphylococcus lugdunensis induces biofilm formation under low-iron growth conditions.

Authors:  Antonino Missineo; Antonella Di Poto; Joan A Geoghegan; Simonetta Rindi; Simon Heilbronner; Valentina Gianotti; Carla Renata Arciola; Timothy J Foster; Pietro Speziale; Giampiero Pietrocola
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Clinical and microbiological characteristics of community-acquired Staphylococcus lugdunensis infections in Southern Taiwan.

Authors:  An-Bang Wu; Ming-Cheng Wang; Chin-Chung Tseng; Wei-Hung Lin; Ching-Hao Teng; Ay-Huey Huang; Kuei-Hsiang Hung; Chuan Chiang-Ni; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

3.  Clinical significance of a single Staphylococcus lugdunensis-positive blood culture.

Authors:  Hind J Fadel; Robin Patel; Emily A Vetter; Larry M Baddour
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

4.  Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.

Authors:  Ian H McHardy; Jennifer Veltman; Janet Hindler; Katia Bruxvoort; Marissa M Carvalho; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

5.  Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia.

Authors:  Seong-Ho Choi; Jin-Won Chung; Eun Jung Lee; Tae Hyong Kim; Mi Suk Lee; Jae Myung Kang; Eun Hee Song; Jae-Bum Jun; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

6.  Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.

Authors:  Lior Nesher; Jeffery Tarrand; Roy F Chemaly; Kenneth Vi Rolston
Journal:  Support Care Cancer       Date:  2016-11-24       Impact factor: 3.603

7.  Is Sinusitis Innocent?--Unilateral Subdural Empyema in an Immunocompetent Child.

Authors:  Sevim Şahin; Uğur Yazar; Ali Cansu; Sibel Kul; Selçuk Kaya; Elif Bahat Özdoğan
Journal:  Indian J Pediatr       Date:  2015-05-14       Impact factor: 1.967

8.  Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.

Authors:  Florian Hitzenbichler; Michaela Simon; Bernd Salzberger; Frank Hanses
Journal:  Infection       Date:  2016-09-22       Impact factor: 3.553

Review 9.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.

Authors:  N Papapetropoulos; M Papapetropoulou; A Vantarakis
Journal:  Infection       Date:  2012-12-16       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.